Blocking SQSTM1 by administering neutralizing monoclonal antibodies or deleting the INSR or SQSTM1 genes in bone marrow cells (BMCs) effectively safeguards mice from fatal sepsis.279, 280. This evidence concerns the gene INSR and Sepsis.